Literature DB >> 27079828

Virus-specific thermostability and heat inactivation profiles of alphaviruses.

So Lee Park1, Yan-Jang S Huang1, Wei-Wen Hsu2, Susan M Hettenbach3, Stephen Higgs1, Dana L Vanlandingham4.   

Abstract

Serological diagnosis is a critical component for disease surveillance and is important to address the increase in incidence and disease burden of alphaviruses, such as the chikungunya (CHIKV) and Ross River (RRV) viruses. The gold standard for serological diagnosis is the plaque reduction neutralization test (PRNT), which demonstrates the neutralizing capacity of serum samples after the removal of complement activity and adventitious viruses. This procedure is normally performed following inactivation of the virus at 56°C for 30min. Although this protocol has been widely accepted for the inactivation of envelope RNA viruses, recent studies have demonstrated that prolonged heat inactivation is required to completely inactivate two alphaviruses, Western equine encephalitis virus and CHIKV. Incomplete inactivation of viruses poses a laboratory biosafety risk and can also lead to spurious test results. Despite its importance in ensuring the safety of laboratory personnel as well as test integrity, systematic investigation on the thermostability of alphaviruses has not been performed. In this study, the temperature tolerance and heat inactivation profiles of RRV, Barmah Forest, and o'nyong-nyong viruses were determined. Variations in thermostability were observed within the Semliki forest serocomplex. Therefore, evidence-based heat inactivation procedures for alphaviruses are recommended.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alphavirus; Heat inactivation; Thermostability

Mesh:

Year:  2016        PMID: 27079828     DOI: 10.1016/j.jviromet.2016.04.004

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  Inactivation and Removal of Chikungunya Virus and Mayaro Virus from Plasma-derived Medicinal Products.

Authors:  Constanze Yue; Sebastian Teitz; Tomoyuki Miyabashi; Klaus Boller; Lia Laura Lewis-Ximenez; Sally A Baylis; Johannes Blümel
Journal:  Viruses       Date:  2019-03-07       Impact factor: 5.048

2.  Correlation of the basic reproduction number (R0) and eco-environmental variables in Colombian municipalities with chikungunya outbreaks during 2014-2016.

Authors:  Víctor Hugo Peña-García; Rebecca C Christofferson
Journal:  PLoS Negl Trop Dis       Date:  2019-11-07

3.  Effective inactivation of Nipah virus in serum samples for safe processing in low-containment laboratories.

Authors:  Shumpei Watanabe; Shuetsu Fukushi; Toshihiko Harada; Masayuki Shimojima; Tomoki Yoshikawa; Takeshi Kurosu; Yoshihiro Kaku; Shigeru Morikawa; Masayuki Saijo
Journal:  Virol J       Date:  2020-10-09       Impact factor: 4.099

4.  Heat inactivation of the severe acute respiratory syndrome coronavirus 2.

Authors:  Christophe Batéjat; Quentin Grassin; Jean-Claude Manuguerra; India Leclercq
Journal:  J Biosaf Biosecur       Date:  2021-01-23

Review 5.  Methods of Inactivation of Highly Pathogenic Viruses for Molecular, Serology or Vaccine Development Purposes.

Authors:  Simon Elveborg; Vanessa M Monteil; Ali Mirazimi
Journal:  Pathogens       Date:  2022-02-19

6.  External Quality Assessment for Zika Virus Molecular Diagnostic Testing, Brazil.

Authors:  Sally A Baylis; Johannes Blümel
Journal:  Emerg Infect Dis       Date:  2018-10       Impact factor: 6.883

7.  Development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) thermal inactivation method with preservation of diagnostic sensitivity.

Authors:  Young-Il Kim; Mark Anthony B Casel; Se-Mi Kim; Seong-Gyu Kim; Su-Jin Park; Eun-Ha Kim; Hye Won Jeong; Haryoung Poo; Young Ki Choi
Journal:  J Microbiol       Date:  2020-09-29       Impact factor: 3.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.